Literature DB >> 33509206

High prevalence of anti-SARS-CoV-2 IgG antibody in the Xikrin of Bacajá (Kayapó) indigenous population in the brazilian Amazon.

João Farias Guerreiro1, Antonio Carlos Rosário Vallinoto2, Eliene Putira Sacuema Rodrigues1, Isabella Nogueira Abreu3, Carlos Neandro Cordeiro Lima3, Dennyson Leandro Mathias da Fonseca1, Sávio Felipe Gomes Pereira4, Laena Costa Dos Reis5, Izaura Maria Vieira Cayres Vallinoto3.   

Abstract

The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reached the Brazilian Amazon and spread among indigenous populations. In the present study, we demonstrate a high prevalence of infection among the Xikrin of Bacajá people (Kayapó). A sample of 100 individuals of both sexes (51 men and 49 women) with ages ranging from 2 to 82 years were clinically evaluated and tested for the presence of anti-SARS-CoV-2 IgG antibody. Among all investigated individuals, 58 were IgG-reactive (58 %) by a rapid test, and 73 (73 %) were reactive in an enzyme-linked immunosorbent assay, with no difference between sexes. Oxygen saturation ranged from 82 to 99 %, with the lowest value observed in a two-year-old girl. The results show that as expected, SARS-CoV-2 infection rapidly reached more than 70 % of the population, most likely because of the difficulties of maintaining social distance due to cultural characteristics. These results highlight the importance of indigenous health policies as a means of minimizing the impact of the pandemic on these communities.

Entities:  

Keywords:  Amazonia; COVID-19; Indigenous peoples; Xikrin

Mesh:

Substances:

Year:  2021        PMID: 33509206      PMCID: PMC7841757          DOI: 10.1186/s12939-021-01392-8

Source DB:  PubMed          Journal:  Int J Equity Health        ISSN: 1475-9276


  12 in total

1.  Herd Immunity and Implications for SARS-CoV-2 Control.

Authors:  Saad B Omer; Inci Yildirim; Howard P Forman
Journal:  JAMA       Date:  2020-11-24       Impact factor: 56.272

2.  Preliminary study on relationships among nutritional risk, serum prealbumin, and peripheral blood T cell subsets in patients with severe COVID-19.

Authors:  Yanli Li; Yanbo Sun; Jing He; Peng Zhao; Pengju Luo; Jinsong Bai; Weiming Li; Shumin Li; Yueying Lin; Yunyun Cen
Journal:  Infect Dis (Lond)       Date:  2020-08-31

3.  Indigenous communities in Brazil fear pandemic's impact.

Authors:  Ignacio Amigo
Journal:  Science       Date:  2020-04-24       Impact factor: 47.728

4.  Cytokine genes are associated with tuberculin skin test response in a native Brazilian population.

Authors:  Verônica M Zembrzuski; Paulo C Basta; Sidia M Callegari-Jacques; Ricardo V Santos; Carlos E A Coimbra; Francisco M Salzano; Mara H Hutz
Journal:  Tuberculosis (Edinb)       Date:  2009-12-14       Impact factor: 3.131

5.  A serological assay to detect SARS-CoV-2 seroconversion in humans.

Authors:  Fatima Amanat; Daniel Stadlbauer; Shirin Strohmeier; Thi H O Nguyen; Veronika Chromikova; Meagan McMahon; Kaijun Jiang; Guha Asthagiri Arunkumar; Denise Jurczyszak; Jose Polanco; Maria Bermudez-Gonzalez; Giulio Kleiner; Teresa Aydillo; Lisa Miorin; Daniel S Fierer; Luz Amarilis Lugo; Erna Milunka Kojic; Jonathan Stoever; Sean T H Liu; Charlotte Cunningham-Rundles; Philip L Felgner; Thomas Moran; Adolfo García-Sastre; Daniel Caplivski; Allen C Cheng; Katherine Kedzierska; Olli Vapalahti; Jussi M Hepojoki; Viviana Simon; Florian Krammer
Journal:  Nat Med       Date:  2020-05-12       Impact factor: 53.440

6.  SARS-CoV-2-specific T cells without antibodies.

Authors:  Cansu Cimen Bozkus
Journal:  Nat Rev Immunol       Date:  2020-08       Impact factor: 53.106

7.  High prevalence of human T-lymphotropic virus 2 (HTLV-2) infection in villages of the Xikrin tribe (Kayapo), Brazilian Amazon region.

Authors:  Isabel Luís Jocene Braço; Keyla Santos Guedes de Sá; Mishelle Waqasi; Maria Alice Freitas Queiroz; Andréa Nazaré Rangel da Silva; Izaura M V Cayres-Vallinoto; Sandra Souza Lima; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak; João Farias Guerreiro; Antonio Carlos Rosário Vallinoto
Journal:  BMC Infect Dis       Date:  2019-05-22       Impact factor: 3.090

8.  The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil.

Authors:  Karoline Rodrigues Campos; Fabiana Aparecida Alves; Marcílio Figueiredo Lemos; Regina Célia Moreira; Rosa Maria Nascimento Marcusso; Adele Caterino-de-Araujo
Journal:  PLoS Negl Trop Dis       Date:  2020-05-26

9.  Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.

Authors:  Lewis F Buss; Carlos A Prete; Claudia M M Abrahim; Alfredo Mendrone; Tassila Salomon; Cesar de Almeida-Neto; Rafael F O França; Maria C Belotti; Maria P S S Carvalho; Allyson G Costa; Myuki A E Crispim; Suzete C Ferreira; Nelson A Fraiji; Susie Gurzenda; Charles Whittaker; Leonardo T Kamaura; Pedro L Takecian; Pedro da Silva Peixoto; Marcio K Oikawa; Anna S Nishiya; Vanderson Rocha; Nanci A Salles; Andreza Aruska de Souza Santos; Martirene A da Silva; Brian Custer; Kris V Parag; Manoel Barral-Netto; Moritz U G Kraemer; Rafael H M Pereira; Oliver G Pybus; Michael P Busch; Márcia C Castro; Christopher Dye; Vítor H Nascimento; Nuno R Faria; Ester C Sabino
Journal:  Science       Date:  2020-12-08       Impact factor: 47.728

10.  High incidence of false-positive results of IgG antibody against SARS-CoV-2 with rapid immunochromatographic antibody test due to human common cold coronavirus infection.

Authors:  Shun Shibata; Takashi Ishiguro; Yasuhito Kobayashi; Mayumi Koike; Tsuyoshi Numano; Yoshihiko Shimizu; Noboru Takayanagi
Journal:  Respir Med Case Rep       Date:  2020-07-25
View more
  6 in total

1.  The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant.

Authors:  David Hodgson; Stefan Flasche; Mark Jit; Adam J Kucharski
Journal:  Euro Surveill       Date:  2021-05

2.  Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.

Authors:  Nathália M S Sansone; Matheus N Boschiero; Manoela M Ortega; Isadora A Ribeiro; Andressa O Peixoto; Roberto T Mendes; Fernando A L Marson
Journal:  Lancet Reg Health Am       Date:  2022-01-07

3.  Seroprevalence and lethality by SARS-CoV-2 in indigenous populations of Latin America and the Caribbean: a systematic review.

Authors:  Akram Hernández-Vásquez; Fabian Chavez-Ecos; Antonio Barrenechea-Pulache; Daniel Comandé; Guido Bendezu-Quispe
Journal:  PeerJ       Date:  2021-12-16       Impact factor: 2.984

4.  Retrospective epidemiology of the SARS-CoV-2 (and COVID-19) epidemic among 27 Brazilian cities.

Authors:  Sandra Souza Lima; Maria Alice Freitas Queiroz; Luiz Fernando Almeida Machado; Antonio Carlos Rosário Vallinoto; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak
Journal:  J Clin Virol Plus       Date:  2021-11-08

5.  Anti-SARS-CoV-2 antibodies among indigenous populations of the Brazilian Amazon: a cross-sectional study.

Authors:  Carlos Neandro Cordeiro Lima; Isabella Nogueira Abreu; Eliene Putira Sacuena Rodrigues; Vanessa de Oliveira Freitas; Bruno José Sarmento Botelho; Sandra Lima Souza; Izaura Cayres-Vallinoto; João Farias Guerreiro; Ricardo Ishak; Antonio C R Vallinoto
Journal:  BMJ Open       Date:  2022-02-07       Impact factor: 2.692

6.  COVID-19 epidemic in remote areas of the French Amazon, March 2020 to May 2021: Another reality.

Authors:  Loïc Epelboin; Tiphanie Succo; Céline Michaud; Margot Oberlis; Bastien Bidaud; Pauline Naudion; Lise Dudognon; Clara Fernandes; Charlène Cochet; Cécile Caspar; Estelle Jacoud; Sébastien Teissier; Maylis Douine; Dominique Rousset; Claude Flamand; Félix Djossou; Mathieu Nacher; Cyril Rousseau; Nicolas Vignier; Mélanie Gaillet
Journal:  Rev Soc Bras Med Trop       Date:  2022-04-29       Impact factor: 2.141

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.